Last reviewed · How we verify
NCT05210777
Norms and Validation for IntelliSpace Cognition Spanish Version
trial testing observation in Cognitive Functioning of Healthy Individuals in 99 participants. Completed in 19 May 2022.
15 April 2022
Quick facts
| Lead sponsor | Philips Electronics Nederland B.V. acting through Philips CTO organization |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 99 |
| Start date | 31 January 2022 |
| Primary completion | 15 April 2022 |
| Estimated completion | 19 May 2022 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- observation
Conditions studied
- Cognitive Functioning of Healthy Individuals — all drugs for Cognitive Functioning of Healthy Individuals →
- Hispanic — all drugs for Hispanic →
Sponsor
Philips Electronics Nederland B.V. acting through Philips CTO organization
Who can join
18 and older, any sex, with Cognitive Functioning of Healthy Individuals or Hispanic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to validate and provide applicable norms for the United States (US) Spanish versions of the IntelliSpace Cognition (ISC) neuropsychological tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05210777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of observation
Trials testing the same drug.
- NCT06493448 — Prospective Observational Cohort Study · not yet recruiting
- NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
- NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
- NCT06327165 — Predictability of ANI (Analgesia Nociception Index) for Spinal Hypotension · unknown
- NCT06114446 — The Evaluation of the Effectiveness of Nursing Care Education Provided With Immersive Virtual Reality · NA · completed
Other Philips Electronics Nederland B.V. acting through Philips CTO organization trials
Trials by the same sponsor.
- NCT05748184 — Fast Ultra Low Dose CT Interpretation · terminated
- NCT05657665 — Skin Tone Measurement Method Investigation for Pulse Oximetry · completed
- NCT05089955 — Children's MRI Experience · NA · completed
- NCT05517096 — AmbuLatory Pediatric Asthma CAre · NA · withdrawn
- NCT05540444 — RadConnect Communication Application · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05210777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philips Electronics Nederland B.V. acting through Philips CTO organization
- Last refreshed: 18 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05210777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing